Reviewed clinical summary · Source-linked · Educational use only

Does Vitamin D Supplementation Improve IVF Outcomes in Women with PCOS?

Hormone Insight visual abstract summarising vitamin D supplementation before IVF in women with PCOS.
Visual abstract for vitamin D supplementation before IVF in women with PCOS.

Clinical Bottom Line

A large BMJ trial finds vitamin D before IVF raises blood levels but does not improve live birth rates in women with PCOS. PICO summary and expert commentary.

Summary: In a large multicentre trial in women with polycystic ovary syndrome undergoing IVF, vitamin D 4000 IU daily for up to 90 days raised serum 25-hydroxyvitamin D but did not improve live birth rates after the first embryo transfer.

PICO Summary

ElementDetail
Population876 women with polycystic ovary syndrome undergoing IVF across 24 fertility centres in China (865 analysed).
InterventionVitamin D 4000 IU/day for up to 90 days before IVF (n=435).
ComparisonPlacebo (n=430).
OutcomeTrigger-day 25-OHD higher with vitamin D (32.3 vs 18.2 ng/mL; adjusted difference 13.6; 95% CI 10.9–16.3). Live birth after first transfer 52.0% vs 50.2% (adjusted risk ratio 1.03; 95% CI 0.91–1.18). Severe ovarian hyperstimulation syndrome in 3 vs 6.
RCT BMJ · 2026

Vitamin D before IVF in PCOS

RCT · PCOS · up to 90 days

Trial design
Women with PCOS, IVF Enrolled & assessed RANDOMISED 1:1 Vitamin D Vitamin D 4000 IU/day n = 435 Placebo Matching placebo n = 430 Live birth after first transfer
Between-group effect (95% CI)
0 (no difference) 0.5 1.5 Live birth (RR)+1.03 Risk ratio (95% CI) · ✓ = significant
Live birth (vit D)
52.0%
First transfer
Live birth (placebo)
50.2%
First transfer
Risk ratio
1.03
95% CI 0.91-1.18
25-OHD difference
+13.6
ng/mL, adjusted
⬡ Bottom Line

Vitamin D raised serum 25-OHD but did not improve live birth after the first embryo transfer in women with PCOS undergoing IVF.

Expert Commentary

Vitamin D is endlessly proposed as a fix for PCOS-related subfertility on the back of observational associations, so a large, multicentre, double-blind trial with the outcome that actually matters, live birth, is exactly what the question deserved. The result is cleanly negative, and I find it convincing: the supplement did what supplements do, it raised serum 25-OHD substantially, but the live birth rate was essentially identical at around 51% in both arms, with a risk ratio sitting on 1.0 and a tight confidence interval. This is the recurring lesson of the vitamin D literature, that correcting a blood level is not the same as changing a clinical outcome. The trial is well powered and well conducted, and the population was mildly deficient at baseline, so this is not explained away by everyone being replete. Can I use this with my patients? Yes, as clear counselling: I will not recommend vitamin D to women with PCOS specifically to improve their IVF success, because it does not. I would still correct documented deficiency for general health reasons, but I would not let anyone delay or pin fertility hopes on it.

References

Hu KL, Liao T, Wu Q, et al. Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trial. BMJ. 2026;392:e087438. doi:10.1136/bmj-2025-087438

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.